• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疟原虫疟疾免疫个体对与恶性疟原虫抗原Pf155/RESA不同区域序列相对应的合成肽的T细胞和B细胞反应

T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA.

作者信息

Troye-Blomberg M, Riley E M, Perlmann H, Andersson G, Larsson A, Snow R W, Allen S J, Houghten R A, Olerup O, Greenwood B M

机构信息

Department of Immunology, University of Stockholm, Sweden.

出版信息

J Immunol. 1989 Nov 1;143(9):3043-8.

PMID:2478632
Abstract

The C-terminal (3') amino acid repeat region of the Plasmodium falciparum Ag Pf155/RESA, a vaccine candidate, contains immunodominant T and B cell epitopes. In order to identify additional T cell epitopes in the molecule, synthetic peptides corresponding to the centrally (5') located repeat region, as well as to four nonrepeated regions, were synthesized. T cells from 46 P. falciparum-primed individuals living in a holoendemic area of The Gambia where malaria transmission is seasonal were tested for their responsiveness to the peptides by thymidine incorporation and IFN-gamma release. There was a considerable variation in the response to different peptides. Proliferation and IFN-gamma release were not correlated in individual donors, underlining the importance of measuring both activities when screening donor populations for total T cell responsiveness to a given Ag. Whereas 72% of the donors responded with proliferation and/or IFN-gamma release to the intact protein the mean % responders to the peptides was 40%. The most frequent responses (up to 60%) were induced with peptides from the 3'- and 5'-repeat region of the protein. Analysis of some closely related sequences in the 3'-repeat region indicated that they contained at least two epitopes that were either distinct or cross-reacting in different donors, suggesting difference in the genetic control of these responses. When the same peptides were investigated for reactivity with antibodies, the best T cell inducing sequences also displayed the best antibody reactivities. However, in individual donors, T and B cell responses were not correlated. T cell responses were shown to persist after a period with no P. falciparum transmission, whereas antibody concentrations tended to decrease, suggesting differences in the requirements of boosting at the T and B cell levels, respectively.

摘要

恶性疟原虫抗原Pf155/RESA的C末端(3')氨基酸重复区域是一种候选疫苗,包含免疫显性T细胞和B细胞表位。为了鉴定该分子中其他的T细胞表位,合成了与位于中央(5')的重复区域以及四个非重复区域相对应的合成肽。对生活在冈比亚疟疾传播呈季节性的高度流行地区、曾感染过恶性疟原虫的46名个体的T细胞,通过掺入胸苷和释放γ干扰素来检测其对这些肽的反应性。对不同肽的反应存在相当大的差异。在个体供体中,增殖和γ干扰素释放不相关,这突出了在筛选供体群体对给定抗原的总T细胞反应性时同时检测这两种活性的重要性。虽然72%的供体对完整蛋白有增殖和/或γ干扰素释放反应,但对肽的平均反应供体百分比为40%。最常见的反应(高达60%)是由该蛋白3'和5'重复区域的肽诱导的。对3'重复区域中一些密切相关序列的分析表明,它们至少包含两个在不同供体中要么不同要么交叉反应的表位,这表明这些反应的遗传控制存在差异。当研究相同的肽与抗体的反应性时,诱导T细胞反应最佳的序列也表现出最佳的抗体反应性。然而,在个体供体中,T细胞和B细胞反应不相关。T细胞反应在无恶性疟原虫传播一段时间后仍持续存在,而抗体浓度则趋于下降,这分别表明在T细胞和B细胞水平上增强免疫的需求存在差异。

相似文献

1
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA.恶性疟原虫疟疾免疫个体对与恶性疟原虫抗原Pf155/RESA不同区域序列相对应的合成肽的T细胞和B细胞反应
J Immunol. 1989 Nov 1;143(9):3043-8.
2
Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.恶性疟原虫疟疾中的人体免疫反应。与Pf155/RESA抗原已知表位相对应的合成肽在体外可诱导产生寄生虫特异性抗体。
J Immunol. 1991 Oct 1;147(7):2295-301.
3
T- and B-cell responses of malaria immune individuals to synthetic peptides corresponding to non-repeat sequences in the N-terminal region of the Plasmodium falciparum antigen Pf155/RESA.疟疾免疫个体对恶性疟原虫抗原Pf155/RESA N端区域非重复序列对应的合成肽的T细胞和B细胞反应
Acta Trop. 1997 Oct 14;68(1):37-51. doi: 10.1016/s0001-706x(97)00070-3.
4
T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine.恶性疟原虫疟疾疫苗的主要候选抗原Pf155/RESA中的T细胞表位
Proc Natl Acad Sci U S A. 1988 Aug;85(15):5659-63. doi: 10.1073/pnas.85.15.5659.
5
Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.对来自印度疟疾流行区成年人中恶性疟原虫明确的血液期抗原(主要裂殖子表面抗原)的细胞免疫和体液免疫反应。
Infect Immun. 1994 Feb;62(2):685-91. doi: 10.1128/iai.62.2.685-691.1994.
6
T cell reactivity of defined peptides from a major Plasmodium falciparum vaccine candidate: the Pf155/RESA antigen.
Immunol Lett. 1988 Nov;19(3):229-33. doi: 10.1016/0165-2478(88)90147-2.
7
Production by activated human T cells of interleukin 4 but not interferon-gamma is associated with elevated levels of serum antibodies to activating malaria antigens.活化的人类T细胞产生白细胞介素4而非干扰素-γ与针对活化疟原虫抗原的血清抗体水平升高有关。
Proc Natl Acad Sci U S A. 1990 Jul;87(14):5484-8. doi: 10.1073/pnas.87.14.5484.
8
Identification of T epitopes within a potential Plasmodium falciparum vaccine antigen. A study of human lymphocyte responses to repeat and nonrepeat regions of Pf155/RESA.恶性疟原虫潜在疫苗抗原中T细胞表位的鉴定。人体淋巴细胞对Pf155/RESA重复和非重复区域反应的研究。
J Immunol. 1988 Nov 1;141(9):3197-202.
9
Characterization of regulatory T cell responses to defined immunodominant T cell epitopes of the Plasmodium falciparum antigen Pf155/RESA.
Immunol Lett. 1990 Aug;25(1-3):129-34. doi: 10.1016/0165-2478(90)90103-w.
10
Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.恶性疟原虫血液期抗原Pf155/RESA诱导的人类调节性T细胞反应的特征
Behring Inst Mitt. 1994 Dec(95):97-105.

引用本文的文献

1
CD4 T-cell expression of IFN-γ and IL-17 in pediatric malarial anemia.儿童疟疾贫血中IFN-γ和IL-17的CD4 T细胞表达
PLoS One. 2017 Apr 20;12(4):e0175864. doi: 10.1371/journal.pone.0175864. eCollection 2017.
2
CD4 T-cell subsets in malaria: TH1/TH2 revisited.疟疾中的CD4 T细胞亚群:重新审视TH1/TH2
Front Immunol. 2015 Jan 12;5:671. doi: 10.3389/fimmu.2014.00671. eCollection 2014.
3
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues.
所有疟原虫免疫表位数据的荟萃分析:疟疾免疫生物学及疫苗相关问题的概述与应用
Parasite Immunol. 2009 Feb;31(2):78-97. doi: 10.1111/j.1365-3024.2008.01077.x.
4
The transcriptome of the intraerythrocytic developmental cycle of Plasmodium falciparum.恶性疟原虫红细胞内发育周期的转录组
PLoS Biol. 2003 Oct;1(1):E5. doi: 10.1371/journal.pbio.0000005. Epub 2003 Aug 18.
5
The mechanism and significance of deletion of parasite-specific CD4(+) T cells in malaria infection.疟疾感染中寄生虫特异性CD4(+) T细胞缺失的机制及意义。
J Exp Med. 2002 Apr 1;195(7):881-92. doi: 10.1084/jem.20011174.
6
Antibodies to a non-repeat region of Plasmodium falciparum antigen Pf155/RESA in individuals from malaria-endemic areas.疟疾流行地区个体中针对恶性疟原虫抗原Pf155/RESA非重复区域的抗体。
Clin Exp Immunol. 1999 Jun;116(3):493-9. doi: 10.1046/j.1365-2249.1999.00911.x.
7
Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys.四种恶性疟原虫红细胞前期抗原在夜猴中的免疫原性
Infect Immun. 1998 Jul;66(7):3423-8. doi: 10.1128/IAI.66.7.3423-3428.1998.
8
Quantification of the relative contribution of major histocompatibility complex (MHC) and non-MHC genes to human immune responses to foreign antigens.主要组织相容性复合体(MHC)和非MHC基因对人类对外源抗原免疫反应的相对贡献的量化。
Infect Immun. 1997 Mar;65(3):872-6. doi: 10.1128/IAI.65.3.872-876.1997.
9
Quantification of antibody-secreting lymphocytes that react with Pf155/RESA from Plasmodium falciparum: an ELISPOT assay for field studies.与恶性疟原虫Pf155/RESA发生反应的抗体分泌淋巴细胞的定量分析:一种用于现场研究的ELISPOT检测法
Clin Exp Immunol. 1993 Jan;91(1):63-7. doi: 10.1111/j.1365-2249.1993.tb03355.x.
10
Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic.对来自印度疟疾流行区成年人中恶性疟原虫明确的血液期抗原(主要裂殖子表面抗原)的细胞免疫和体液免疫反应。
Infect Immun. 1994 Feb;62(2):685-91. doi: 10.1128/iai.62.2.685-691.1994.